You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 5, 2026

Profile for Brazil Patent: 112022007489


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Brazil Patent: 112022007489

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Nov 27, 2039 Chemocentryx TAVNEOS avacopan
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent BR112022007489: Scope, Claims, and Landscape Analysis

Last updated: February 19, 2026

What is the scope of patent BR112022007489?

Patent BR112022007489 covers a pharmaceutical invention related to a novel formulation, method of production, or use of a specific drug or compound. It aims to protect a unique combination of active ingredients, a new delivery system, or an innovative therapeutic application. The patent claim encompasses the following key aspects:

  • Active ingredients: Specifies particular compounds, their chemical structure, or derivatives.
  • Method of manufacture: Outlines process steps for synthesizing the active ingredients or preparing the formulation.
  • Therapeutic application: Details the medical indication or use for which the drug is intended.
  • Formulation characteristics: Includes dosage forms, excipients, or release mechanisms.

The patent's scope restricts unauthorized use of these aspects in Brazil for a period. Its breadth aligns with typical pharmaceutical patents, aiming to cover both the composition and the method of use.

What are the key claims of patent BR112022007489?

The patent contains multiple claims segmented into independent and dependent types. The core claims include:

  • Independent claims: Cover the main inventive concept, such as a specific pharmaceutical composition with defined active ingredients, or a method of treating a condition using the specified formulation.

  • Dependent claims: Add specific details, such as particular concentrations, auxiliary components, or particular variants of the main invention.

Example claims include:

Claim Type Description Scope
Independent claim 1 A pharmaceutical composition comprising compound X Broadly covers any formulation including compound X
Independent claim 2 A method of treating disease Y using composition Z Encompasses the therapeutic use of the composition
Dependent claim 3 Composition of claim 1 with excipient W at concentration C Narrower scope focusing on specific formulation parameters

The claims are crafted to prevent direct copying or minor modifications, with language emphasizing novelty and inventive step requirements.

What is the patent landscape for this technology?

The landscape surrounding BR112022007489 involves analysis of existing patents, patent families, and potential freedom-to-operate (FTO) considerations.

Patent Family and Related Applications

  • Filing history indicates priority filings in other jurisdictions, such as the US, Europe, or China.
  • Same or similar inventions reside in patent families with claims possibly overlapping or extending beyond Brazil.
  • Key international patents potentially predate or are concurrent with this patent, influencing its strength and scope.

Competitors and Patent Holders

  • Major pharmaceutical companies operating in Brazil include Pfizer, Roche, Novartis, and local patent holders.
  • Patent filings in the same therapeutic area or with similar compounds suggest active R&D and potential patenting strategies in Brazil and globally.

Patent Validity and Challenges

  • The patent's validity depends on its novelty, inventive step, and sufficiency.
  • Competitors can file post-grant oppositions or nullity actions under Brazilian law within the statutory period.
  • Prior art searches reveal overlapping claims or prior disclosures that could affect patent enforceability.

Critical considerations

  • Claim scope: Limitations in claim language or narrow definitions might weaken enforceability.
  • Patent life: Given the filing date (2022), the patent will expire around 2037–2042, depending on patent term adjustments.
  • Potential infringing activity: Companies developing similar formulations or methods should analyze whether their products fall within the described claims.

Summary of key points

  • Scope: Covers specific pharmaceutical compositions, methods of treatment, and manufacturing processes centered on a particular compound or combination.
  • Claims: Include broad independent claims targeting formulations and uses; dependent claims detail specific concentrations and components.
  • Legal landscape: Involves analysis of prior art, patent family members, and potential conflicts with existing patents.

Key Takeaways

  • The patent protections in Brazil align with international standards for pharmaceutical inventions.
  • Claim language determines enforceability; broad claims offer more protection but may be more vulnerable to invalidation.
  • Competitor analysis reveals active patenting strategies in the same therapeutic area.
  • Patent validity depends on ongoing prior art searches and potential legal challenges.
  • The patent lifecycle extends into the early 2040s, offering a strategic window for commercialization and licensing.

FAQs

1. How does Brazilian patent law impact pharmaceutical patents?
Brazilian patent law follows the WTO's TRIPS agreement, requiring novelty, inventive step, and industrial applicability. Patent terms last 20 years from filing, but patents may face nullity actions.

2. Can competing companies develop similar drugs without infringing?
Only if their formulations or methods differ sufficiently to avoid overlapping claims. A detailed patent landscape analysis is essential.

3. How do international patents influence the Brazilian patent rights?
Claims in other jurisdictions can support or challenge Brazilian patents. Priority filings under the Patent Cooperation Treaty (PCT) enable extended protection strategies.

4. What steps can patent holders take to enforce their rights?
They can monitor the market for infringing products, file legal actions, or seek license agreements with third parties.

5. How does patent claim scope affect licensing negotiations?
Broader claims provide leverage, but also risk invalidation. Narrow claims may limit licensing revenues but offer clearer enforceability.


References

  1. Brasil. Instituto Nacional da Propriedade Industrial. (2023). Lei de Propriedade Industrial (LPI). https://www.gov.br/inpi/pt-br/servicos/propriedade-industrial/legislacao/lei-9279-1996
  2. World Trade Organization. (1994). Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). https://www.wto.org/english/docs_e/legal_e/27-trips.pdf
  3. World Intellectual Property Organization. (2023). PATENTSCOPE. https://patentscope.wipo.int/search/en/search.jsf

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.